EE624 Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the Vaccination Programme in the UK
| Autor: | Hunjan, M, Curran, D, Marijam, A, Schamroth, J, Vekria, Y, Giannelos, N |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S178-S179 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect